Citation Impact
Citing Papers
A Comparison of Rate Control and Rhythm Control in Patients with Atrial Fibrillation
2002 Standout
Prospective Study of Obstructive Sleep Apnea and Incident Coronary Heart Disease and Heart Failure
2010 Standout
Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation
2009 Standout
CD4+ Count–Guided Interruption of Antiretroviral Treatment
2006 Standout
A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling
2007 StandoutNobel
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Heart rate turbulence-based predictors of fatal and nonfatal cardiac arrest (The autonomic tone and reflexes after myocardial infarction substudy)
2002
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Heart-Rate Profile during Exercise as a Predictor of Sudden Death
2005 Standout
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
2013 Standout
Prevention of Implantable-Defibrillator Shocks by Treatment with Sotalol
1999
Depressed heart rate variability identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone
2000
Risk of cancer in persons with AIDS in Italy, 1985–1998
2003
Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations
2003
Consecutive screening and enrollment in clinical trials: The way to representative patient samples?
1998
Dofetilide in Patients with Congestive Heart Failure and Left Ventricular Dysfunction
1999
Wound repair and regeneration
2008 StandoutNature
Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials
2003
Acetylcholine from vagal stimulation protects cardiomyocytes against ischemia and hypoxia involving additive non‐hypoxic induction of HIF‐1α
2005
Exercise Standards for Testing and Training
2013 Standout
Cause of death in clinical research
1999
Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events
2009 Standout
Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation
2011
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation
2002
The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure
2005 Standout
Soft-Tissue Sarcomas in Adults
2005 Standout
Prognosis determination in heart failure
2001
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction
2002 Standout
The MUSTT Study: Evaluating Testing and Treatment
2000
Amiodarone for the prevention of sudden cardiac death: a meta-analysis of randomized controlled trials
2009
A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery Disease
1999 Standout
Value of non-invasive and invasive studies in patients with bundle branch block, syncope and history of myocardial infarction
2001
Acute Stressors and Cortisol Responses: A Theoretical Integration and Synthesis of Laboratory Research.
2004 Standout
Sudden Cardiac Death: Exploring the Limits of Our Knowledge
2001
A Phase I Study of Ampligen in Human Immunodeficiency Virus-Infected Subjects
1992
Papillomaviruses and cancer: from basic studies to clinical application
2002 StandoutNobel
Antiarrhythmic Therapies for the Prevention of Sudden Cardiac Death
1997
Salvage Therapy for Refractory or Relapsed Acute Lymphocytic Leukemia
2001
Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias
1999
Virologic and immunologic values allowing safe deferral of antiretroviral therapy
2002
Human papillomavirus and cervical cancer
2007 Standout
Myocarditis
2011 Standout
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
2009 Standout
A Comparison of Rate Control and Rhythm Control in Patients with Recurrent Persistent Atrial Fibrillation
2002 Standout
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Natural History and Possible Reactivation of Human Papillomavirus in Human Immunodeficiency Virus–Positive Women
2005
Task Force on Sudden Cardiac Death of the European Society of Cardiology
2001
Myocarditis
2000 Standout
Prevalence of Oral HPV Infection in the United States, 2009-2010
2012 Standout
Sudden Death Due to Cardiac Arrhythmias
2001
Predictors of appropriate implantable cardioverter-defibrillator therapy in patients with idiopathic dilated cardiomyopathy
2002
Predicting Mortality Among Patients Hospitalized for Heart Failure
2003 Standout
Carvedilol's antiarrhythmic properties: Therapeutic implications in patients with left ventricular dysfunction
2005
Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis
2007 Standout
Age-Specific Prevalence of Infection with Human Papillomavirus in Females: A Global Review
2008
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Protective Effect of Amiodarone but Not N-Desethylamiodarone on Postischemic Hearts through the Inhibition of Mitochondrial Permeability Transition
2003
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
2005 Standout
Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
2005 Standout
Increased Mortality after Dronedarone Therapy for Severe Heart Failure
2008
Myocarditis
2009 Standout
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Canadian Implantable Defibrillator Study (CIDS)
2000
A Decade of Clinical Trial Developments in Postmyocardial Infarction, Congestive Heart Failure, and Sustained Ventricular Tachyarrhythmia Patients: From CAST to AVID and Beyond
1998
Causal attributions predict rate of immune decline in HIV-seropositive gay men.
1996
Single Center Experience of a New Intensive Induction Therapy for Ewing’s Family of Tumors: Feasibility, Toxicity, and Stem Cell Mobilization Properties
2003
A Comparison of Antiarrhythmic-Drug Therapy with Implantable Defibrillators in Patients Resuscitated from Near-Fatal Ventricular Arrhythmias
1997 Standout
Characterization of Different Subsets of Atrial Fibrillation in General Practice in France
1999
Human papillomavirus–associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers
2001
Direct Gene Transfer into Mouse Muscle in Vivo
1990 StandoutScience
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Amiodarone Interaction With β-Blockers
1999
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
2006
American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death
2008
Part 9: Post–Cardiac Arrest Care
2010 Standout
The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial
2011 Standout
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
Long-Term Comparison of the Implantable Cardioverter Defibrillator Versus Amiodarone
2004
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death
2008
Sudden Cardiac Death
1998 Standout
Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist Device
2009 Standout
Preparation and characterization of an intravenous solution of IgG from human immunodeficiency virus-seropositive donors
1991
Design and Results of the Antiarrhythmics vs Implantable Defibrillators (AVID) Registry
1999
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive Summary
2006
Multicenter Automatic Defibrillator Implantation Trial II (MADIT II): Design and Clinical Protocol
1999
Persistent human immunodeficiency virus type 1 infection of monoblastoid cells leads to accumulation of self-integrated viral DNA and to production of defective virions
1989
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2006
HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction—pharmacological approaches
1999
Efficacy and Safety of Oral Dofetilide in Converting to and Maintaining Sinus Rhythm in Patients With Chronic Atrial Fibrillation or Atrial Flutter
2000
Passive immunotherapy in AIDS: a double-blind randomized study based on transfusions of plasma rich in anti-human immunodeficiency virus 1 antibodies vs. transfusions of seronegative plasma.
1995 StandoutNobel
The microbial mimic poly IC induces durable and protective CD4+T cell immunity together with a dendritic cell targeted vaccine
2008 StandoutNobel
Use of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation
2000
Determinants of HIV Progression and Assessment of the Optimal Time to Initiate Highly Active Antiretroviral Therapy
2008
Works of A Muñoz being referenced
Evaluation of the Effectiveness of Highly Active Antiretroviral Therapy in Persons with Human Immunodeficiency Virus using Biomarker-based Equivalence of Disease Progression
2002
Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT
1997
Megatherapy in children with high-risk Ewing’s sarcoma in first complete remission
1998
Cervical Neoplasia and Repeated Positivity of Human Papillomavirus Infection In Human Immunodeficiency Virus-seropositive and -seronegative Women
2000
Autologous bone marrow transplantation with monoclonal antibody purged marrow for children with acute lymphoblastic leukemia in second remission
1998
Predictors of decline in CD4 lymphocytes in a cohort of homosexual men infected with human immunodeficiency virus.
1988